Skip to content
healthcare.dev

Pepto Bismol

NDC 67751-155, BISMUTH SUBSALICYLATE, tablet, chewable, from Navajo Manufacturing Company Inc..

Product NDC
67751-155
Status
Listed
Labeler
Navajo Manufacturing Company Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M008
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67751-155 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISMUTH SUBSALICYLATE262 mg/1
Package NDCNDC-11Package
67751-155-01677510155011 POUCH in 1 CARTON (67751-155-01) / 2 TABLET, CHEWABLE in 1 POUCH
67751-155-02677510155021 POUCH in 1 CARTON (67751-155-02) / 4 TABLET, CHEWABLE in 1 POUCH
67751-155-06677510155063 POUCH in 1 CARTON (67751-155-06) / 2 TABLET, CHEWABLE in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 67751-155 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67751-155 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67751-155. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.